| 摘要 |
Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof. |
| 申请人 |
IDENIX PHARMACEUTICALS, INC. |
发明人 |
DOUSSON, CYRIL B.;DUKHAN, DAVID;PARSY, CHRISTOPHE CLAUDE;PIERRA, CLAIRE;ALEXANDRE, FRANCOIS-RENE;BRANDT, GUILLAUME;DA COSTA, DANIEL;RAHALI, HOUCINE;PAPARIN, JEAN-LAURENT;DEROCK, MICHEL;CONVARD, THIERRY;SURLERAUX, DOMINIQUE |
